N30 Pharmaceuticals is now Nivalis Therapeutics, Inc.
Nivalis Therapeutics is headquartered in Boulder, Colorado. Our company is small, but passionate and growing. We have transitioned from an early-stage company focused on preclinical exploration, to a clinical-stage company that is translating bench-side science into patient benefit. As part of this evolution, we changed our company name to Nivalis, a name that communicates the commitment, passion, and energy we are bringing to the Cystic Fibrosis community as we strive to discover and develop innovative solutions that improve and extend the lives of people managing CF.